✦ LIBER ✦

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: A meta-analysis of major clinical trials

✍ Scribed by Paul G. Shekelle; Michael W. Rich; Sally C. Morton; Col.Sid W. Atkinson; Wenli Tu; Margaret Maglione; Shannon Rhodes; Michael Barrett; Gregg C. Fonarow; Barry Greenberg; Paul A. Heidenreich; Tom Knabel; Marvin A. Konstam; Anthony Steimle; Lynne Warner Stevenson

Book ID: 119545516
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 176 KB
Volume: 41
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(03)00262-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Tolerability of Angiotensin-C

Safety and Tolerability of Angiotensin-Converting Enzyme Inhibitor Versus the Combination of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker in Patients With Left Ventricular Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

✍ Rachid Lakhdar; Mouaz H. Al-Mallah; David E. Lanfear 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Tissue angiotensin-converting enzyme inh

Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials

✍ S. A. Saha; J. Molnar; R. R. Arora 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB